Key facts
- Notable investors include Zhuhai Hecheng Zhiyi Capital Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jiayu Biology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiayu Biology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiayu Biology
Manufacturer of biotechnology products intended for diagnostic, therapeutic, and research applications. The company offers reagent development, medical device engineering, and technical consulting across biological and medical domains, enabling healthcare institutions and research organizations to access tailored tools for cell therapy, precision diagnostics, and laboratory workflows with scalable customization and regulatory compliance support.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Jiayu Biology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiayu Biology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiayu Biology in its N-PORT filings yet. We sweep new filings monthly.